Search

Search Constraints

You searched for: Author/Creator Hahn, Noah M.

Search Results

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

2. A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer. Issue 20 (5th August 2020)

4. Evaluation of gender‐based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database. (17th May 2017)

5. Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes. Issue 8 (23rd September 2021)

6. Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes. Issue 8 (September 2021)

7. Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival. Issue 1 (27th January 2022)

8. Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes. Issue 4 (20th December 2018)

9. MP56-08 CLINICOPATHOLOGIC AND SURVIVAL AFTER CYSTECTOMY OUTCOMES IN SQUAMOUS CELL CARCINOMA OF THE BLADDER. (May 2022)

10. Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs. (9th April 2017)